AU2315388A - Use of atrial peptide antibodies, receptor antagonists, and atrial peptide synthesis inhibitors in controlling renal and systemic vasodilation in diabetes mellitus - Google Patents

Use of atrial peptide antibodies, receptor antagonists, and atrial peptide synthesis inhibitors in controlling renal and systemic vasodilation in diabetes mellitus

Info

Publication number
AU2315388A
AU2315388A AU23153/88A AU2315388A AU2315388A AU 2315388 A AU2315388 A AU 2315388A AU 23153/88 A AU23153/88 A AU 23153/88A AU 2315388 A AU2315388 A AU 2315388A AU 2315388 A AU2315388 A AU 2315388A
Authority
AU
Australia
Prior art keywords
atrial peptide
diabetes mellitus
receptor antagonists
synthesis inhibitors
peptide synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23153/88A
Inventor
Barbara J. Ballermann
Barry M. Brenner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU2315388A publication Critical patent/AU2315388A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU23153/88A 1987-07-17 1988-07-18 Use of atrial peptide antibodies, receptor antagonists, and atrial peptide synthesis inhibitors in controlling renal and systemic vasodilation in diabetes mellitus Abandoned AU2315388A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7464287A 1987-07-17 1987-07-17
US074642 1987-07-17

Publications (1)

Publication Number Publication Date
AU2315388A true AU2315388A (en) 1989-02-13

Family

ID=22120747

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23153/88A Abandoned AU2315388A (en) 1987-07-17 1988-07-18 Use of atrial peptide antibodies, receptor antagonists, and atrial peptide synthesis inhibitors in controlling renal and systemic vasodilation in diabetes mellitus

Country Status (2)

Country Link
AU (1) AU2315388A (en)
WO (1) WO1989000428A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2859684B2 (en) * 1990-04-10 1999-02-17 協和醗酵工業株式会社 New physiologically active substance HS-142-1 and method for producing the same
FR2669538B1 (en) * 1990-11-28 1995-03-03 Fondation Nale Transfusion San USE OF LOCALLY ADMINISTERED IMMUNOGLOBULINS IN THE TREATMENT OF EPITHELIAL INFECTIONS.
US5965533A (en) * 1997-05-23 1999-10-12 Baxter International Inc. Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
CN101977594B (en) * 2008-02-01 2015-09-02 B.R.A.H.M.S有限公司 Suffer from the authentication method of patient and the treatment of this patient that mild cognitive impairment needs treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4557864A (en) * 1984-01-10 1985-12-10 Washington University Atrial peptides
US4757048A (en) * 1985-11-05 1988-07-12 Biotechnology Research Associates J.V. Synthetic analogs of atrial natriuretic peptides

Also Published As

Publication number Publication date
WO1989000428A1 (en) 1989-01-26

Similar Documents

Publication Publication Date Title
CA2071908A1 (en) Antibody antagonists of human interleukin-4
CA2312667A1 (en) Novel cytokine
AU2460988A (en) Simultaneous immunoassay for the determination of antigens and antibodies
WO1999060119A3 (en) Multivalent t cell receptor complexes
AU583818B2 (en) Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
AU4617689A (en) Composition for controlled release of polypeptides
AU6223986A (en) Potent,selective opioid receptor agonists and antagonists
AU4225889A (en) Peptide synthesis method and solid support for use in the method
AU625613B2 (en) Novel chimeric antibodies
AU4493685A (en) Polyclonal antibodies, preparation and use
AU5780890A (en) Tetrazole excitatory amino acid receptor antagonists
AU4591389A (en) Process for making creamy instant agglomerated cereal
AU2315388A (en) Use of atrial peptide antibodies, receptor antagonists, and atrial peptide synthesis inhibitors in controlling renal and systemic vasodilation in diabetes mellitus
AU2097592A (en) Fibrinogen-specific monoclonal antibody and uses thereof
AU3330689A (en) Monoclonal antibodies
GB2223579B (en) Verocytotoxin receptor assay
AU3651789A (en) Novel neplanocin derivatives
AU3108389A (en) Polypeptides
AU4242489A (en) Theophylline assay
AU4812390A (en) Pyrazole-containing juvenile hormone mimics for pest control, compositions and use
AU4450389A (en) Anti-fucosylcermiade monoclonal antibody
AU3910989A (en) Thermal dye transfer-dye receptor construction
AU591579B2 (en) Antibodies for use in determining human glycoalbumin
IL86710A0 (en) Polypeptide receptor for interleukin-2,antibodies against this polypeptide and pharmaceutical compositions containing the same
IL85944A0 (en) 5-pyrazinyl-1,3,4-oxadiazole and thia-diazole derivatives their preparation and their use as nematicides